News

@AJMC_Journal
ajmc.com > view > 2025-outlook-tackling-ai-cybersecurity-and-regulatory-challenges

2025 Outlook: Tackling AI, Cybersecurity, and Regulatory Challenges | AJMC

2025 Outlook: Tackling AI, Cybersecurity, and Regulatory Challenges | AJMC3+ hour, 25+ min ago   (218+ words) This is how health care organizations are addressing compliance pressures, cybersecurity threats, and the rise of artificial intelligence (AI) amid resource constraints and evolving regulations. Against this backdrop, the 2025 Healthcare Compliance Outlook report2 sheds light on evolving risks and offers guidance…...

@AJMC_Journal
ajmc.com > view > potential-biomarkers-of-rsv-bronchiolitis-severity-identified

Potential Biomarkers of RSV Bronchiolitis Severity Identified | AJMC

Potential Biomarkers of RSV Bronchiolitis Severity Identified | AJMC2+ day, 14+ hour ago   (479+ words) Respiratory syncytial virus (RSV) remains a leading cause of acute bronchitis in children, but new research may enable earlier intervention. Scientists have identified new biomarkers that appear to predict severity and the risk of wheezing recurrence in children with respiratory…...

@AJMC_Journal
ajmc.com > view > genome-wide-analysis-uncovers-genetic-drivers-of-ipd-and-its-overlap-with-covid-19

Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19 | AJMC

Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19 | AJMC2+ mon, 2+ day ago   (310+ words) Common and rare genetic variants linked to idiopathic pulmonary fibrosis (IPF) and reveals substantial genetic overlap with severe COVID-19, highlighting shared biological pathways and potential therapeutic targets. A large-scale genomic investigation has identified new genetic risk factors for idiopathic pulmonary…...

@AJMC_Journal
ajmc.com > view > immune-checkpoint-inhibitors-safe-to-use-for-nsclc-in-patients-with-hiv

Immune Checkpoint Inhibitors Safe to Use for NSCLC in Patients With HIV | AJMC

Immune Checkpoint Inhibitors Safe to Use for NSCLC in Patients With HIV | AJMC3+ mon, 5+ day ago   (269+ words) The efficacy of immune checkpoint inhibitors was found in patients with both HIV and non'small cell lung cancer (NSCLC), though more inclusion of people with HIV is needed in future studies. Patients with both HIV and non'small cell lung cancer…...

@AJMC_Journal
ajmc.com > journals > issue > 2016 > 2016-5-vol22-SP > Time-to-End-Insurance-Restrictions-on-Life-Saving-Hepatitis-C-Treatments

Special Issue: HCV | The American Journal of Managed Care | Journals | AJMC

Special Issue: HCV | The American Journal of Managed Care | Journals | AJMC4+ mon, 2+ week ago   (219+ words) Advances in treatment for hepatitis C virus (HCV) have the potential to generate considerable spillover benefits to patients awaiting transplants, especially among those with non'HCV-mediated liver failure. The authors examine real-world hepatitis C virus cure rates with direct-acting antivirals among…...

ajmc.com
ajmc.com > view > future-therapies-targeting-epstein-barr-virus-could-help-combat-ms

Future Therapies Targeting Epstein-Barr Virus Could Help Combat MS

Future Therapies Targeting Epstein-Barr Virus Could Help Combat MS5+ mon, 1+ week ago   (497+ words) Research highlights a strong link between Epstein-Barr virus and multiple sclerosis (MS), suggesting new therapeutic strategies targeting the virus for MS treatment. It is difficult to pinpoint a single cause of multiple sclerosis (MS), but for years, researchers have suspected…...

AJMC
ajmc.com > view > acc017-showed-safety-tolerability-when-used-as-antiretroviral-therapy

ACC017 Showed Safety, Tolerability When Used as Antiretroviral Therapy

ACC017 Showed Safety, Tolerability When Used as Antiretroviral Therapy5+ mon, 1+ week ago   (452+ words) New abstracts from the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2025 found that ACC017 showed promise in its use as an antiretroviral therapy. The novel integrase strand transfer inhibitor (INSTI), ACC017, was found to be effective and…...

AJMC
ajmc.com > view > covid-19-s-hidden-toll-noah-greenspan-dpt-pt-on-inflammation-flares-and-recovery

COVID-19’s Hidden Toll: Noah Greenspan, DPT, on Inflammation, Flares, and Recovery

COVID-19’s Hidden Toll: Noah Greenspan, DPT, on Inflammation, Flares, and Recovery7+ mon, 3+ week ago   (152+ words) Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City, reflects on how the reality of COVID-19 infection proved far more complex than initially thought. There are 2 earlier…...

AJMC
ajmc.com > view > the-argument-against-routine-antibiotics-for-patients-with-nonsevere-covid-19

The Argument Against Routine Antibiotics for Patients With Nonsevere COVID-19

The Argument Against Routine Antibiotics for Patients With Nonsevere COVID-198+ mon, 3+ week ago   (529+ words) Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm associated with routine early antibiotic treatment, supporting antibiotic stewardship to limit unnecessary use. Early antibiotic treatment showed no meaningful benefit for hospitalized patients with nonsevere…...

AJMC
ajmc.com > view > hiv-cure-the-goal-of-future-study-into-genetic-tagging-benjamin-k-chen-md-phd

HIV Cure the Goal of Future Study Into Genetic Tagging: Benjamin K. Chen, MD, PhD

HIV Cure the Goal of Future Study Into Genetic Tagging: Benjamin K. Chen, MD, PhD9+ mon, 2+ week ago   (391+ words) Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in targeting HIV cells. Benjamin K. Chen, MD, PhD, professor in the Division of Infectious Diseases, Department of Medicine in the Icahn…...